ÂÜÀòÂÒÂ×

Markus Kramer is a Senior Manager at CureVac, leading the team in Analytical Development. Prior to this role, Markus served as the Senior Scientist and Team Lead in Biophysical Chemistry at CureVac, focusing on analytical method development and drug product characterization for mRNA-based formulations. Before their time at CureVac, Markus worked as a Scientist in Early Process Development, specializing in lipid nanoparticle-based vaccines. Markus also has experience in operating accounting at the Institute for Organic Chemistry at the University of Stuttgart and as a chemical engineer at Universität Stuttgart. Markus holds a Ph.D. in Chemistry from the University of Stuttgart.